Towards safer blood transfusion

By Our Special Correspondent

BANGALORE, OCT. 2. The New Delhi-based Haemotech Inc. has announced the launch in India of two systems for the collection and management of blood which promise to alleviate two major problems of blood supply in this country - shortage and safety. The two products are the intellectual property of the U.S.-based Haemonetics Corporation, world leaders in blood processing technology.

The Haemonetics cell saver autologous blood recovery system collects a patient's own blood during surgery, cleanses it and recycles elements of the blood back to the patient before he leaves the operating theatre. This blood salvaging process reduces or eliminates the need for surgery patients to receive blood drawn from others.

The MCS apheresis system permits the collection of therapeutically useful quantities of blood components from a donor. The rest of the blood is automatically returned to the donor. Unlike traditional manual collection processes, the blood collected through apheresis requires no further processing before transfusion to a patient, making it an efficient and cost effective procedure for blood centres.

Send this article to Friends by E-Mail

Section  : Business
Previous : Split businesses for overseas listing - Nasdaq VP
Next     : Sales of scooters, mopeds drop, bikes rise